Targeted genes and interacting proteins of hypoxia inducible factor-1

International Journal of Biochemistry and Molecular Biology

Volumn 3, Issue 2, 2012, Pages 165-178

  Liu, Wei ^a   Shen, Shao Ming ^a   Zhao, Xu Yun ^a   Chen Dr , Guo Qiang ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Hypoxia inducible factor 1alpha; Interacting protein; Targeting gene

Indexed keywords

ANGIOPOIETIN 2; CALCITONIN RECEPTOR LIKE RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE INHIBITOR 1; G PROTEIN COUPLED RECEPTOR; GELATINASE B; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASE 7; HYPOXIA INDUCIBLE FACTOR 1; INTERFERON REGULATORY FACTOR 1; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; SCATTER FACTOR RECEPTOR; SEMAPHORIN; SEMAPHORIN 4D; SMAD3 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR RUNX1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANGIOGENESIS; APOPTOSIS; CELL DIFFERENTIATION; CHONDROGENESIS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE TARGETING; METASTASIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; TRANSACTIVATION; TRANSCRIPTION INITIATION; TUMOR GROWTH; UBIQUITINATION;

EID: 84862487817     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Wang GL, Jiang BH, Rue EA and Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loophelix- PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
2. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998; 8: 588-594.
3. Wang GL and Semenza GL. Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 1996; 3: 156-162.
4. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732.
5. Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2010; 2: 336-361.
6. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW and Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2 -regulated prolyl hydroxylation. Science 2001; 292: 468-472.
7. Song LP, Zhang J, Wu SF, Huang Y, Zhao Q, Cao JP, Wu YL, Wang LS and Chen GQ. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Oncogene 2008; 27: 519-527.
8. Huang Y, Du KM, Xue ZH, Yan H, Li D, Liu W, Chen Z, Zhao Q, Tong JH, Zhu YS and Chen GQ. Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor- 1alpha. Leukemia 2003; 17: 2065-2073.
9. Wenger RH and Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997; 378: 609-616.
10. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC and Xavier RJ. An integrative genomics approach identifies Hypoxia Inducible Factor -1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 2009; 37: 4587-4602.
11. Ortiz-Barahona A, Villar D, Pescador N, Amigo J and del Peso L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res 2010; 38: 2332-2345.
12. Han YH, Xia L, Song LP, Zheng Y, Chen WL, Zhang L, Huang Y, Chen GQ and Wang LS. Comparative proteomic analysis of hypoxia-treated and untreated human leukemic U937 cells. Proteomics 2006; 6: 3262-3274.
13. Liao SH, Zhao XY, Han YH, Zhang J, Wang LS, Xia L, Zhao KW, Zheng Y, Guo M and Chen GQ. Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells. Proteomics 2009; 9: 3901-3912.
14. Wenger RH, Stiehl DP and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005; 2005: re12.
15. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835.
16. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC and Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
17. Lee SH, Lee YJ and Han HJ. Role of hypoxia-induced fibronectin-integrin beta1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK. J Cell Physiol 2011; 226: 484-493.
18. Cowden Dahl KD, Robertson SE, Weaver VM and Simon MC. Hypoxia-inducible factor regu lates alphavbeta3 integrin cell surface expression. Mol Biol Cell 2005; 16: 1901-1912.
19. Ryu MH, Park HM, Chung J, Lee CH and Park HR. Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin. Biochem Biophys Res Commun 2010; 393: 11-15.
20. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH and Semenza GL. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725-2731.
21. Luo Y, He DL, Ning L, Shen SL, Li L, Li X, Zhau HE and Chung LW. Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro. BJU Int 2006; 98: 1315-1319.
22. O'Toole EA, van Koningsveld R, Chen M and Woodley DT. Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway. J Cell Physiol 2008; 214: 47-55.
23. Lin MT, Kuo IH, Chang CC, Chu CY, Chen HY, Lin BR, Sureshbabu M, Shih HJ and Kuo ML. Involvement of hypoxia-inducing factor-1alphadependent plasminogen activator inhibitor-1 up -regulation in Cyr61/CCN1-induced gastric cancer cell invasion. J Biol Chem 2008; 283: 15807-15815.
24. Buchler P, Reber HA, Tomlinson JS, Hankinson O, Kallifatidis G, Friess H, Herr I and Hines OJ. Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer. Neoplasia 2009; 11: 196-206.
25. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S and Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347-361.
26. Ishikawa T, Nakashiro K, Klosek SK, Goda H, Hara S, Uchida D and Hamakawa H. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep 2009; 21: 707-712.
27. Li Y, Qiu X, Zhang S, Zhang Q and Wang E. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. Cancer Biol Ther 2009; 8: 322-330.
28. Kotch LE, Iyer NV, Laughner E and Semenza GL. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999; 209: 254-267.
29. Tsuzuki Y, Fukumura D, Oosthuyse B, Koike C, Carmeliet P and Jain RK. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 2000; 60: 6248-6252.
30. Nikitenko LL, Smith DM, Bicknell R and Rees MC. Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. Faseb J 2003; 17: 1499-1501.
31. Sun Q, Zhou H, Binmadi NO and Basile JR. Hypoxia- inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 2009; 284: 32066-32074.
32. Han ZB, Ren H, Zhao H, Chi Y, Chen K, Zhou B, Liu YJ, Zhang L, Xu B, Liu B, Yang R and Han ZC. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008; 29: 1853-1861.
33. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA and Semenza GL. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxiainducible factor 1. Circ Res 2003; 93: 1074-1081.
34. Cheng J, Kang X, Zhang S and Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007; 131: 584-595.
35. Xu Y, Zuo Y, Zhang H, Kang X, Yue F, Yi Z, Liu M, Yeh ET, Chen G and Cheng J. Induction of SENP1 in endothelial cells contributes to hypoxia-driven VEGF expression and angiogenesis. J Biol Chem 2010; 285: 36682-36688.
36. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
37. Hayashi M, Sakata M, Takeda T, Yamamoto T, Okamoto Y, Sawada K, Kimura A, Minekawa R, Tahara M, Tasaka K and Murata Y. Induction of glucose transporter 1 expression through hypoxia- inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol 2004; 183: 145-154.
38. Calvert JW, Cahill J, Yamaguchi-Okada M and Zhang JH. Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol 2006; 101: 853-865.
39. Liu Y, Li YM, Tian RF, Liu WP, Fei Z, Long QF, Wang XA and Zhang X. The expression and significance of HIF-1alpha and GLUT-3 in glioma. Brain Res 2009; 1304: 149-154.
40. Obach M, Navarro-Sabate A, Caro J, Kong X, Duran J, Gomez M, Perales JC, Ventura F, Rosa JL and Bartrons R. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxiainducible factor-1 binding sites necessary for transactivation in response to hypoxia. J Biol Chem 2004; 279: 53562-53570.
41. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, Simon MC and Thompson CB. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev 2007; 21: 1037-1049.
42. Rodriguez H, Drouin R, Holmquist GP and Akman SA. A hot spot for hydrogen peroxide-induced damage in the human hypoxia-inducible factor 1 binding site of the PGK 1 gene. Arch Biochem Biophys 1997; 338: 207-212.
43. Kress S, Stein A, Maurer P, Weber B, Reichert J, Buchmann A, Huppert P and Schwarz M. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998; 124: 315-320.
44. Ullah MS, Davies AJ and Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281: 9030-9037.
45. Kim JW, Tchernyshyov I, Semenza GL and Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
46. Papandreou I, Cairns RA, Fontana L, Lim AL and Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187-197.
47. Corn PG, Ricci MS, Scata KA, Arsham AM, Simon MC, Dicker DT and El-Deiry WS. Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis. Cancer Biol Ther 2005; 4: 1285-1294.
48. Zhang H, Gao P, Fukuda R, Kumar G, Krishnamachary B, Zeller KI, Dang CV and Semenza GL. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 2007; 11: 407-420.
49. Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, Shima H, Johnson RS, Hirao A, Suematsu M and Suda T. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010; 7: 391-402.
50. Ezashi T, Das P and Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 2005; 102: 4783-4788.
51. Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA, Simon MC and Keith B. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006; 20: 557-570.
52. Helczynska K, Kronblad A, Jogi A, Nilsson E, Beckman S, Landberg G and Pahlman S. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003; 63: 1441-1444.
53. Jogi A, Ora I, Nilsson H, Poellinger L, Axelson H and Pahlman S. Hypoxia-induced dedifferentiation in neuroblastoma cells. Cancer Lett 2003; 197: 145-150.
54. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U and Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617-628.
55. Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 2009; 114: 2015-2019.
56. Jiang Y, Xue ZH, Shen WZ, Du KM, Yan H, Yu Y, Peng ZG, Song MG, Tong JH, Chen Z, Huang Y, Lubbert M and Chen GQ. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1 alpha that augments transcriptional activity of CCAAT/ enhancer-binding protein-alpha. Leukemia 2005; 19: 1239-1247.
57. Kim JS, Cho EW, Chung HW and Kim IG. Effects of Tiron, 4,5-dihydroxy-1,3-benzene disulfonic acid, on human promyelotic HL-60 leukemia cell differentiation and death. Toxicology 2006; 223: 36-45.
58. Zhang J, Song LP, Huang Y, Zhao Q, Zhao KW and Chen GQ. Accumulation of hypoxiainducible factor-1 alpha protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid. Haematologica 2008; 93: 1480-1487.
59. Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC and Chen GQ. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood 2006; 107: 698-707.
60. Zhang J and Chen GQ. Hypoxia-HIF-1alpha-C/EBPalpha/Runx1 signaling in leukemic cell differentiation. Pathophysiology 2009; 16: 297-303.
61. Zhao XY, Zhao KW, Jiang Y, Zhao M and Chen GQ. Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J Biol Chem 2011; 286: 36808-36819.
62. Zhao XY, Chen TT, Xia L, Guo M, Xu Y, Yue F, Jiang Y, Chen GQ and Zhao KW. Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells. Carcinogenesis 2010; 31: 1367-1375.
63. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS and Zelzer E. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 2007; 134: 3917-3928.
64. Hammond EM, Dorie MJ and Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 2003; 278: 12207-12213.
65. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.
66. Yu J, Wang Z, Kinzler KW, Vogelstein B and Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 2003; 100: 1931-1936.
67. Hsieh JK, Kletsas D, Clunn G, Hughes AD, Schachter M and Demoliou-Mason C. p53, p21 (WAF1/CIP1), and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 973-981.
68. Chipuk JE and Green DR. Cytoplasmic p53: bax and forward. Cell Cycle 2004; 3: 429-431.
69. Hansson LO, Friedler A, Freund S, Rudiger S and Fersht AR. Two sequence motifs from HIF- 1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci USA 2002; 99: 10305-10309.
70. Chen D, Li M, Luo J and Gu W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 2003; 278: 13595-13598.
71. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998; 392: 405-408.
72. Li J, Zhang X, Sejas DP, Bagby GC and Pang Q. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 2004; 279: 41275-41279.
73. Buhler K, Plaisance I, Dieterle T and Brink M. The human urocortin 2 gene is regulated by hypoxia: identification of a hypoxia-responsive element in the 3'-flanking region. Biochem J 2009; 424: 119-127.
74. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000; 97: 9082-9087.
75. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 2000; 20: 5454-5468.
76. Kim JY, Ahn HJ, Ryu JH, Suk K and Park JH. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 2004; 199: 113-124.
77. Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin WG, Jr., Elledge SJ, Conaway RC, Harper JW and Conaway JW. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 1999; 284: 657-661.
78. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M and Krek W. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin- protein ligase activity. Genes Dev 1999; 13: 1822-1833.
79. Stebbins CE, Kaelin WG, Jr. and Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 1999; 284: 455-461.
80. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG, Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468.
81. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, Yoo MA, Song EJ, Lee KJ and Kim KW. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002; 111: 709-720.
82. Chowdhury R, Hardy A and Schofield CJ. The human oxygen sensing machinery and its manipulation. Chem Soc Rev 2008; 37: 1308-1319.
83. Kaelin WG Jr and Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393-402.
84. Bruick RK and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337-1340.
85. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ and Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
86. Berra E, Benizri E, Ginouves A, Volmat V, Roux D and Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 2003; 22: 4082-4090.
87. Baek JH, Mahon PC, Oh J, Kelly B, Krishnamachary B, Pearson M, Chan DA, Giaccia AJ and Semenza GL. OS-9 interacts with hypoxiainducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell 2005; 17: 503-512.
88. Yoo YG, Kong G and Lee MO. Metastasisassociated protein 1 enhances stability of hypoxia- inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J 2006; 25: 1231-1241.
89. Baek JH, Liu YV, McDonald KR, Wesley JB, Hubbi ME, Byun H and Semenza GL. Spermidine/ spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1alpha. J Biol Chem 2007; 282: 23572-23580.
90. Li Z, Wang D, Messing EM and Wu G. VHL protein- interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha. EMBO Rep 2005; 6: 373-378.
91. Li Z, Wang D, Na X, Schoen SR, Messing EM and Wu G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem Biophys Res Commun 2002; 294: 700-709.
92. Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS and Chun YS. ATP6V0C competes with von Hippel-Lindau protein in hypoxiainducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1. Mol Pharmacol 2007; 71: 942-948.
93. Moon EJ, Jeong CH, Jeong JW, Kim KR, Yu DY, Murakami S, Kim CW and Kim KW. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J 2004; 18: 382-384.
94. Gradin K, McGuire J, Wenger RH, Kvietikova I, fhitelaw ML, Toftgard R, Tora L, Gassmann M and Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol 1996; 16: 5221-5231.
95. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F and Neckers LM. Hsp90 regulates a von Hippel Lindau-independent hypoxiainducible factor-1 alpha-degradative pathway. J Biol Chem 2002; 277: 29936-29944.
96. Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J and Michiels C. Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett 1999; 460: 251-256.
97. Liu YV, Baek JH, Zhang H, Diez R, Cole RN and Semenza GL. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)- independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 2007; 25: 207-217.
98. Liu YV and Semenza GL. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007; 6: 656-659.
99. Baek JH, Liu YV, McDonald KR, Wesley JB, Zhang H and Semenza GL. Spermidine/ spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha. J Biol Chem 2007; 282: 33358-33366.
100. Amir S, Wang R, Simons JW and Mabjeesh NJ. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation. J Biol Chem 2009; 284: 11142-11151.
101. Kong X, Lin Z, Liang D, Fath D, Sang N and Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 2006; 26: 2019-2028.
102. Kong X, Alvarez-Castelao B, Lin Z, Castano JG and Caro J. Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J Biol Chem 2007; 282: 15498-15505.
103. Zhou J, Schmid T, Frank R and Brune B. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHLindependent degradation. J Biol Chem 2004; 279: 13506-13513.
104. van de Sluis B, Groot AJ, Vermeulen J, van der Wall E, van Diest PJ, Wijmenga C, Klomp LW and Vooijs M. COMMD1 Promotes pVHL and O2 -Independent Proteolysis of HIF-1alpha via HSP90/70. PLoS One 2009; 4: e7332.
105. Koh MY, Darnay BG and Powis G. Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation. Mol Cell Biol 2008; 28: 7081-7095.
106. Koh MY and Powis G. HAF: the new player in oxygen-independent HIF-1alpha degradation. Cell Cycle 2009; 8: 1359-1366.
107. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL and Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia- inducible factor 1alpha. Genes Dev 2000; 14: 34-44.
108. Nieminen AL, Qanungo S, Schneider EA, Jiang BH and Agani FH. Mdm2 and HIF-1alpha interaction in tumor cells during hypoxia. J Cell Physiol 2005; 204: 364-369.
109. Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK, Park JW, Kim KR and Kim KW. Jab1 interacts directly with HIF-1alpha and regulates its stability. J Biol Chem 2002; 277: 9-12.
110. Kang X, Li J, Zou Y, Yi J, Zhang H, Cao M, Yeh ET and Cheng J. PIASy stimulates HIF1alpha SUMOylation and negatively regulates HIF1alpha activity in response to hypoxia. Oncogene 2010; 29: 5568-5578.
111. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, Stalla GK, Holsboer F and Arzt E. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell 2007; 131: 309-323.
112. Amir S, Wang R, Matzkin H, Simons JW and Mabjeesh NJ. MSF-A interacts with hypoxiainducible factor-1alpha and augments hypoxiainducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006; 66: 856-866.
113. Cai Q, Lan K, Verma SC, Si H, Lin D and Robertson ES. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hy poxia: Latency control under low oxygen conditions. J Virol 2006; 80: 7965-7975.
114. Tandle AT, Calvani M, Uranchimeg B, Zahavi D, Melillo G and Libutti SK. Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome. Exp Cell Res 2009; 315: 1850-1859.
115. van de Sluis B, Mao X, Zhai Y, Groot AJ, Vermeulen JF, van der Wall E, van Diest PJ, Hofker MH, Wijmenga C, Klomp LW, Cho KR, Fearon ER, Vooijs M and Burstein E. COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. J Clin Invest 2010; 120: 2119-2130.
116. Fatyol K and Szalay AA. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF- 1alpha) and inhibits HIF-1-mediated transcription. J Biol Chem 2001; 276: 28421-28429.
117. Hagele S, Behnam B, Borter E, Wolfe J, Paasch U, Lukashev D, Sitkovsky M, Wenger RH and Katschinski DM. TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)- 1alpha. FEBS Lett 2006; 580: 3731-3738.
118. Hogenesch JB, Gu YZ, Jain S and Bradfield CA. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci USA 1998; 95: 5474-5479.
119. Hogenesch JB, Gu YZ, Moran SM, Shimomura K, Radcliffe LA, Takahashi JS and Bradfield CA. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J Neurosci 2000; 20: RC83.
120. Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N and Fujii-Kuriyama Y. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. Biochem Biophys Res Commun 1998; 248: 789-794.
121. Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S and Shimeno H. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003; 63: 7277-7283.
122. Chilov D, Hofer T, Bauer C, Wenger RH and Gassmann M. Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J 2001; 15: 2613-2622.
123. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML and Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466-1471.
124. Mahon PC, Hirota K and Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15: 2675-2686.
125. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H and Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxiainducible factor 1alpha. Mol Cell Biol 2000; 20: 402-415.
126. Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L and Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signalinduced interaction with CBP/p300. EMBO J 1999; 18: 1905-1914.
127. Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2: 336-361.
128. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF and Livingston DM. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 1996; 93: 12969-12973.
129. Kato H, Tamamizu-Kato S and Shibasaki F. Histone deacetylase 7 associates with hypoxiainducible factor 1alpha and increases transcriptional activity. J Biol Chem 2004; 279: 41966-41974.
130. Land SC and Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007; 282: 20534-20543.
131. Ao A, Wang H, Kamarajugadda S and Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 2008; 105: 7821-7826.
132. Lim JH, Lee YM, Chun YS, Chen J, Kim JE and Park JW. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 2010; 38: 864-878.
133. Moon HE, Ahn MY, Park JA, Min KJ, Kwon YW and Kim KW. Negative regulation of hypoxia inducible factor-1alpha by necdin. FEBS Lett 2005; 579: 3797-3801.
134. Budde A, Schneiderhan-Marra N, Petersen G and Brune B. Retinoblastoma susceptibility gene product pRB activates hypoxia-inducible factor-1 (HIF-1). Oncogene 2005; 24: 1802-1808.
135. Kaidi A, Williams AC and Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007; 9: 210-217.
136. Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L and Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 276: 38527-38535.
137. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC and Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949-1956.
138. Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, Pardoll DA and Lowenstein CJ. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001; 61: 3682-3688.
139. Koshiji M, To KK, Hammer S, Kumamoto K, Harris AL, Modrich P and Huang LE. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell 2005; 17: 793-803.
140. Zhang W, Tsuchiya T and Yasukochi Y. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J Hum Genet 1999; 44: 293-299.
141. Peng ZG, Zhou MY, Huang Y, Qiu JH, Wang LS, Liao SH, Dong S and Chen GQ. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha. Oncogene 2008; 27: 839-847.
142. Yang L, Jiang Y, Wu SF, Zhou MY, Wu YL and Chen GQ. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis 2008; 29: 291-298.
143. van de Sluis B, Mao X, Zhai Y, Groot AJ, Vermeulen JF, van der Wall E, van Diest PJ, Hofker MH, Wijmenga C, Klomp LW, Cho KR, Fearon ER, Vooijs M and Burstein E. COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. J Clin Invest 2010; 120: 2119-2130.
144. Lee YM, Lim JH, Chun YS, Moon HE, Lee MK, Huang LE and Park JW. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha. Carcinogenesis 2009; 30: 1768-1775.